Aquarius Population Health

Looking at the cost implications of using PCR-based respiratory panel assays for patients admitted to hospital with pneumonia in the UK, France and Spain

Our paper on the cost of using PCR-based respiratory panel assays for patients with pneumonia was published this week in BMC Pulmonary Medicine. This work, funded by the Innovative Health Initiative (IHI), compared the cost of using standard diagnostic tests with the cost of using either an upper respiratory pathogen PCR-based panel test, a lower Read More >

Analysing the COPD care pathway in Japan, Canada, England and Germany: a global view

Aquarius Population Health are delighted to be collaborating with AstraZeneca on a poster session at this year’s European Respiratory Society International Congress. Our research, based on clinician interviews and local data reviews, advances our understanding of COPD care pathways in Japan, Canada, England and Germany, and identifies cross cutting barriers to optimal COPD care, which Read More >